Skip to main content

Thyroid cancer tests that helps to determine the right treatment

Quest Diagnostics, the world’s leading provider of diagnostic testing, information, and services, offers a new molecular test panel designed to help physicians determine if a thyroid gland is cancerous and requires surgical removal. The test is believed to be the most comprehensive panel clinically available to identify mutations associated with 4 gene markers indicated by the American Thyroid Association’s guidelines for clinical management of indeterminate thyroid biopsies.

Solid Tumor Core Panel

Quest also offers a 49-gene Solid Tumor Core Panel to help physicians choose the most appropriate therapy for their patients based on the alterations found in the individual’s tumor sample DNA.

This information is provided for informational purposes only and is not intended as medical advice. A physician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.

Find out what's happening

Learn More